Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod, Cyclophosphamide, and Radiotherapy in Breast Cancer
NCT01421017Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Aug 2011
- Primary completion
- Jul 2016
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of imiquimod in breast cancer, sponsored by NYU Langone Health. Started Aug 2011; status: completed.
02
Drugs
imiquimod
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01421017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01421017.